Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.

3.06
EUR
+0.00
(+0.13%)
-0.52EPS
703.45MMarket Cap
Feb 25Next Earn

Aclaris Therapeutics, Inc. Documents

Q3 FY2021 · Quarterly report

56 pages

Read Aclaris Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this quarterly report
Create a free account to start reading

Full documents are included with Professional

Q3 FY2021 documents